APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Apyx Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.42−0.13 (-5.10%)
Close on Oct 19, 2026
- Market cap
- $106.12M
- P/E (TTM)
- –
- Dividend yield
- –
Apyx Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Market Cap | $101.94M | $229.23M |
| Enterprise Value | $110.08M | $194.73M |
| PS Ratio | 1.75 | 3.14 |
| PB Ratio | 9.56 | 3.19 |
| P/TBV Ratio | 9.56 | 4.69 |
Enterprise value
| Measure | Apyx Medical | Industry median |
|---|---|---|
| EV / Sales | 1.88 | 2.93 |
Income (trailing twelve months)
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Revenue | $58.42M | $102.39M |
| Gross Profit | $37.09M | $60.36M |
| Operating Income | -$3.54M | -$4.31M |
| Pretax Income | -$7.97M | -$2.26M |
| Net Income | -$8.63M | -$6.57M |
| EBITDA | -$2.76M | -$1.98M |
| EPS (Diluted) | -$0.20 | -$0.07 |
Margins
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Gross Margin | 63.5% | 55.1% |
| Operating Margin | -6.06% | -6.04% |
| Pretax Margin | -13.6% | -4.11% |
| Profit Margin | -14.8% | -10.5% |
| EBITDA Margin | -4.72% | -2.67% |
| FCF Margin | -18.9% | -0.30% |
Returns
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Return on Equity (ROE) | -96.4% | -19.2% |
| Return on Assets (ROA) | -14.5% | -13.3% |
| Return on Invested Capital (ROIC) | -18.2% | -4.11% |
| Return on Capital Employed (ROCE) | -6.84% | -9.07% |
Growth
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 25.6% | 8.85% |
| Revenue Growth (3Y CAGR) | 5.89% | 7.08% |
| Revenue Growth (5Y CAGR) | 13.8% | 11.8% |
Balance sheet
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $27.62M | $37.33M |
| Total Debt | $35.33M | $72.66M |
| Net Cash (Debt) | -$7.71M | $3.92M |
| Net Cash Per Share | -$0.18 | $0.28 |
| Equity (Book Value) | $10.66M | $57.36M |
| Book Value Per Share | $0.25 | $2.81 |
| Tangible Book Value | $10.66M | $10.71M |
| Working Capital | $43.80M | $54.64M |
Financial position
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Current Ratio | 5.68 | 2.50 |
| Quick Ratio | 4.41 | 1.54 |
| Debt / Equity | 3.31 | 0.38 |
| Interest Coverage | -0.63 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Operating Cash Flow | -$10.13M | -$653.46K |
| Capital Expenditures | -$920.00K | -$3.69M |
| Free Cash Flow | -$11.05M | -$835.02K |
| FCF Per Share | -$0.26 | -$0.02 |
Efficiency
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.98 | 0.59 |
| Inventory Turnover | 2.25 | 2.21 |
| Revenue Per Employee | $284.95K | $322.75K |
| Profits Per Employee | -$42.12K | -$52.11K |
| Employee Count | 205 | 197 |
Dividends and yields
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Earnings Yield | -8.47% | -6.92% |
| FCF Yield | -10.8% | -0.62% |
Shares
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Shares Outstanding | 42,124,000 | 44,856,700 |
| Shares Change (YoY) | 10.5% | 3.35% |
| Shares Change (QoQ) | 0.59% | 0.27% |
| Float | 39,271,000 | 36,934,400 |
| Shares Held by Insiders | 6.77% | 10.6% |
| Shares Held by Institutions | 58.5% | 63.5% |
Taxes
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Income Tax | $439.00K | $1.52M |
Scores
| Measure | Apyx Medical | Industry median |
|---|---|---|
| Altman Z-Score | 0.68 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -2.63 | -2.64 |
Calculated by StockData from Apyx Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.